Proteoglycans in Lung Disease

Discusses new treatment strategies for malignant mesothelioma, pulmonary edema, fibrosis, asthma, emphysema, and bronchiectasis.

Proteoglycans in Lung Disease considersglycosaminoglycans as novel therapeutic agents or targets in lung disease
the role of proteoglycans in determining mechanical behavior of lung tissue
hyaluronan and its receptors in wound healing, inflammation, vasculogenesis, and angiogenesis
the impact of small proteoglycans on matrix assembly
versican as a modulator of cell adhesion, migration, and proliferation
antiproliferative activity of heparin and its derivatives on pulmonary artery smooth muscle cells
the effects of mechanical strain on proteoglycans
the functions of proteoglycans in the vascular wall
the effect of hypoxia on glycosaminoglycans in the lung
Comprised of more than 1940 references, Proteoglycans in Lung Disease